Navigation Links
Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France
Date:3/15/2012

system by the Institut Gustave Roussy, uncertainties relating to future initial launch and training agreements with other cancer centers in Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to refle
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/s9qx9j/asia_pacific_open ) ... Open System MRI Market - Growth, Trends And ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the fastest growing market for Open System MRI. ... replacing CT because of its higher sensitivity and ...
(Date:5/27/2015)... , May 27, 2015  With all the ... the services they provide to keep patients healthy should ... ripple effect of the Affordable Care Act continues to ... insurance payer partners, making it more important than ever ... communication with those they contract with for patient care. ...
(Date:5/27/2015)... , May 26, 2015 Research and Markets( ... "Asia Pacific Mammography Market - Growth, Trends And Forecasts ... Mammography is a detailed type of imaging ... A mammography exam, called a mammogram, is used to ... diseases in women. An x-ray (radiograph) is a noninvasive ...
Breaking Medicine Technology:Asia Pacific Open System MRI Market Trends and Forecasts 2015-2019 2Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
... Sept. 1, 2011 Hillcrest HealthCare System (HHS) ... Tulsa, Okla., and Claremore Regional Hospital in Claremore, Okla. ... not disclosed. The transaction included the assets ... Claremore Regional Hospital, more than 70 primary care physicians, ...
... 2011 ConvaTec Inc., a world-leading developer and marketer ... today announced that the company has acquired Boston Medical ... platform of specialized medical devices throughout Latin America. ... relationships in key Latin American markets, coupled with strong ...
Cached Medicine Technology:Hillcrest Completes Purchase of SouthCrest & Claremore Hospitals 2ConvaTec Announces Acquisition of Boston Medical Device 2
(Date:5/27/2015)... CURE® Magazine and the Bladder ... advance research, provide information and support, and raise awareness ... fifth most common type of cancer, which begins when ... out of control. , “CURE Magazine provides guidance ... the cancer experience through digital and print publications, live ...
(Date:5/27/2015)... ABILENE, Texas (PRWEB) May 27, 2015 ... addition of three FDA-approved dermal filler treatments in Abilene, ... designed to reduce the appearance of glabellar lines, better ... lines. Belotero Balance® is designed to treat smoker’s ... mouth to the chin, while Radiesse® improves the appearance ...
(Date:5/27/2015)... New York, NY (PRWEB) May 27, 2015 ... excellence, has launched in the U.S. with its first ... products are available for purchase nationwide through http://www.difassusa.com ... to a person’s health and productivity, but some people ... need each night. Dormiva™ is a sleep aid designed ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Coco Libre announced ... be able to reach for Organic Coconut Water to quench ... will be available at VIP areas, artist greenrooms, corporate skyboxes ... available at area hotels and on festival shuttle buses. ... this year,” said Noa Elan, Director of Strategic Partnerships for ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 27, 2015 Cincinnati ... Education & Research for Veterans (CERV) Foundation is proud to ... information fair for women Veterans June 11 at the Freedom ... Reporter Karin Johnson will be the emcee. , This ... and devotion to the nation. The banquet is free ...
Breaking Medicine News(10 mins):Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2
... likely as the rest of the population to die an ... reveals research published ahead of print in the Journal of ... more than 1050 North American and European musicians and singers ... the musicians featured in the All Time Top 1000 albums, ...
... Acquisition of Consultech Strengthens Omnicom,s Presence in China,s Growing ... ... 3 Omnicom Group Inc.,("Omnicom") (NYSE: OMC ), the ... Diversified Agency Services,division ("DAS"), a majority ownership interest in Consultech, ...
... in Nashville, NASHVILLE, Tenn., Aug. 24 ... hold a press conference on,Tuesday, August 28 in ... Drug Administration (FDA) authority over tobacco products. The,leaders ... U.S. Representatives Bart Gordon (D-TN) and Marsha Blackburn,(R-TN) ...
... stomach may cause vitamin C to promote, rather than ... research published ahead of print in the journal Gut. ... fat (lipid) and vitamin C (ascorbic acid) on nitrite ... vulnerable to pre-cancerous changes and tumour growth. , ...
... ability to recover their heart rate variability following acute ... could increase their risk of coronary death, according to ... General Psychiatry, one of the JAMA/Archives journals. However, patients ... may experience more of an improvement in heart rate ...
... visits to a doctors office that resulted in a diagnosis ... 40 times over the last decade, reported researchers funded in ... same time period, the number of visits by adults resulting ... these increases is unclear. Medication prescription patterns for the two ...
Cached Medicine News:Health News:Pop stars more than twice as likely to die an early death 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 3Health News:Tennessee Faith Leaders Call on Reps. Gordon & Blackburn to Co-sponsor Legislation to Protect Kids from Tobacco 2Health News:Treating depression may improve recovery of heart rate variability following coronary syndromes 2Health News:Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults 2Health News:Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults 3Health News:Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults 4Health News:Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults 5
... Mumps IgG ELISA test system is intended ... antibody in human serum. When performed according ... test, together with other clinical information, may ... and/or aid in the diagnosis of Mumps ...
... IgG Enzyme-linked Immunosorbent Assay (ELISA) is intended ... IgG antibody to Mumps virus in human ... for the determination of immune status. Paired ... to demonstrate seroconversion or a significant rise ...
... the TEG analyzer and the TEG analytical software, ... formation and dissolution of the clot, showing the ... TEG analyzer is the only hemostasis analyzer available ... proven model developed by Prof. Helmut Hartert in ...
... BareWire technology, the wire crosses the lesion ... catheter. All other actions, including filter placement ... then occur over the wire., ,Emboshield is ... off during a carotid stenting procedure, and ...
Medicine Products: